Scientific publications



 

  1. Bakker, M.F., Jacobs, J.W.G., Welsing, P.M.J., Vreugdenhil, S.A., Booma-Franfort, C. van, Linn-Rasker, S.P., Ton, E., Lafeber, F.P.J.G. & Bijlsma, J.W.J. (2011). Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study. Annals of the Rheumatic Diseases, 70(6), 1099-1103.
  2. Bakker, M.F., Verstappen, S.M.M., Welsing, P.M.J., Jacobs, J.W.G., Jahangier, Z.N., Veen, M.J. van der, Bijlsma, J.W.J. & Lafeber, F.P.J.G. (2011). The relation between cartilage biomarkers (C2C, C1,2C, CS846, and CPII) and the long-term outcome of rheumatoid arthritis patients within the CAMERA trial. Arthritis Research & Therapy, 13(3), R70-R70.
  3. Bijlsma, J.W.J., Berenbaum, F. & Lafeber, F.P.J.G. (2011). Osteoarthritis: an update with relevance for clinical practice. The Lancet, 18(377 (9783)), 2115-2126.
  4. Blom, D., Thomaes, S.,Kool, M.B., Middendorp, H. van, Lumley, M.A., Bijlsma, J.W.J. & Geenen, R. (2011). A combination of illness invalidation from the work environment and helplessness is associated with embitterment in patients with fibromyalgia. Rheumatology.
  5. Blom, D., Middendorp, H. van & Geenen, R. (2011). Anxious attachment might be a vulnerability factor for developing embitterment. Psychology & Psychotherapy: Theory, Research and Practice.
  6. Bossema, E.R., Kool, M.B., Cornet, D., Vermaas, P., Jong, M. de, Middendorp, H. van & Geenen, R. (2011). Characteristics of suitable work from the perspective of patients with fibromyalgia. Rheumatology.
  7. Bruijn, S.T. de, Wijck, A.J.M. van, Geenen, R., Snijders, T.J., Meulen, W.J.T.M. van der, Jacobs, J.W.G. & Veldhuijzen, D.S. (2011). Relevance of physical fitness levels and exercise-related beliefs for clinical and experimental pain in fibromyalgia: an explorative study. Journal of Clinical Rheumatology.
  8. De Laat, B., Derksen, R.H.W.M., Reber, G., Musial, J., Swadzba, J., Bozic, B., Cucnik, S., Regnault, V., Forastiero, R., Woodhams, B.J. & Groot, P.G. de (2011). An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies. Journal of Thrombosis and Haemostasis, 9(1), 149-153.
  9. Diena va-Verdoold, I., Boon-Spijker, M.G., Groot, P.G. de, Brinkman, H.J., Voorberg, J., Mertens, K., Derksen, R.H.W.M. & Laat, B. de (2011). Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity. Journal of Thrombosis and Haemostasis, 9(4), 738-747.
  10. Erkan, D., Derksen, R.H.W.M., Levy, R., Machin, S., Ortel, T., Pierangeli, S., Roubey, R. & Lockshin, M. (2011). Antiphospholipid Syndrome Clinical Research Task Force report. Lupus, 20(2), 219-224.
  11. Goes, M.C. van der , Bossema, E.R., Hartkamp, A., Godaert, G.L.R., Jacobs, J.W.G., Kruize, A.A., Derksen, R.H.W.M., Bijlsma, J.W.J. & Geenen, R. (2011). Cortisol during the day in patients with systemic lupus erythematosus or primary Sjögren’s syndrome. Journal of Rheumatology, 38(2), 285-288.
  12. Hartgring, S.A.Y., Willis, C.R., Dean, C.E., Broere, F., Eden, W. van, Bijlsma, J.W.J., Lafeber, F.P.J.G. & Roon, J.A.G. van (2011). Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis and Rheumatism, 63(7), 1878-1887.
  13. Hartkamp, A., Geenen, R., Kruize, A.A., Bossema, E.R., Godaert, G.L.R., Bootsma, H., Bijlsma, J.W.J. & Derksen, R.H.W.M. (2011). Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren’s syndrome. Clinical and Experimental Rheumatology, 29(2), 318-321.
  14. Hazlewood, G., Aletaha, D., Carmona, L., Landewé, R.B., Heijde, D.M. van der , Bijlsma, J.W.J., Bykerk, V.P., Canhão, H., Catrina, A.I., Durez, P., Edwards, C.J., Leeb, B.F., Mjaavatten, M.D., Martinez-Osuna, P., Montecucco, C., Ostergaard, M., Serra-Bonett, N., Xavier, R.M., Zochling, J., Machado, P., Thevissen, K., Vercoutere, W. & Bombardier, C. (2011). Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. Journal of Rheumatology, 87, 54-58.
  15. Intema, F., Roermund, P.M. van, Marijnissen, A.C.A , Cotofana, S., Eckstein, F., Castelein, R.M., Bijlsma, J.W.J., Mastbergen, S.C. & Lafeber, F.P.J.G. (2011). Changes in subchondral bone early in development of OA. Arthritis and Rheumatism, 1-7.
  16. Intema, F., Thomas, T.P., Anderson, D.D., Elkins, J.M., Brown, T.D., Amendola, A., Lafeber, F.P.J.G. & Saltzman, C.L. (2011). Subchondral bone remodeling is related to clinical improvement after joint distraction in the treatment of ankle osteoarthritis. Osteoarthritis and cartilage, 19(6), 668-675.
  17. Intema, F., Roermund, P.M. van, Marijnissen, A.C.A , Cotafana, S., Eckstein, F., Castelein, R.M., Bijlsma, J.W.J., Mastbergen, S.C. & Lafeber, F.P.J.G. (2011). Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study. Annals of the Rheumatic Diseases, 70(8), 1441-1446.
  18. Jahangier, Z.N., Jacobs, J.W.G., Swen, W.A., Moolenburgh, J.D., Bruyn, G.A., Griep, E.N. & Bijlsma, J.W.J. (2011). Can simple ultrasonography predict the clinical effect of intra-articular injection therapy of the knee joint? Clinical Rheumatology, 30(6), 749-755.
  19. Kinds, M.B., Welsing, P.M.J., Vignon, E.P., Bijlsma, J.W.J., Viergever, M.A., Marijnissen, A.C.A & Lafeber, F.P.J.G. (2011). A systematic review of the association between radiographic and clinical osteoarthritis of hip and knee. Osteoarthritis and cartilage, 19(7), 768-778.
  20. Kool, M.B. & Geenen, R. (2011). Loneliness in patients with rheumatic diseases: the significance of invalidation and lack of social support. Journal of Psychology.
  21. Kool, M.B.,Middendorp, H. van, Bijlsma, J.W.J. & Geenen, R. (2011). Patient and spouse appraisals of health status in rheumatoid arthritis and fibromyalgia: discrepancies and associations with invalidation. Clinical and Experimental Rheumatology.
  22. Luijn, J.C. van, Danz, M., Bijlsma, J.W.J., Gribnau, F.W. & Leufkens, H.G. (2011). Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept. Scandinavian Journal of Rheumatology, 40(3), 183-191.
  23. Macho do, P., Castrejon, I., Katchamart, W., Bijlsma, J.W.J., Zochling, J. & Bombardier, C. (2011). Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Annals of the Rheumatic Diseases, 70(1), 15-24.
  24. Mastbergen, S.C., Lafeber, F.P. (2011). Changes in subchondral bone early in development of OA. Arthritis and Rheumatism.
  25. Overman, C.L., Bossema, E.R., Middendorp, H. van, Wijngaards-de Meij, L., Verstappen, S.M.M., Bulder, M., Jacobs, J.W.G., Bijlsma, J.W.J. & Geenen, R. (2011). The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis. Annals of the Rheumatic Diseases.
  26. Romay-Penabad, Z., Aguilar-Valenzuela, R., Urbanus, R., Derksen, R.H.W.M., Pennings, M.T., Papalardo, E., Shilagard, T., Vargas, G., Hwang, Y., Groot, P.G. de & Pierangeli, S.S. (2011). Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood, 117(4), 1408-1414.
  27. Ruiz-Irastorza, G., Cuadrado, M.J., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R.H.W.M., Erkan, D., Krilis, S., Machin, S., Pengo, V., Pierangeli, S., Tektonidou, M. & Khamashta, M. (2011). Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus, 20(2), 206-218.
  28. Serror, R., Ravaud, P., Mariette, X., Kruize, A.A., Vitali, C. & Bowman, S.J. (2011). EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Annals of the Rheumatic Diseases,70(6), 968-972.
  29. Ton, E., Tekstra, J., Hellmann, P.M., Nuver-Zwart, I.H.H. & Bijlsma, J.W.J. (2011). Safety of rituximab therapy during twins’pregnancy. Rheumatology (Oxford, England), 50(4), 806-808.
  30. Vriezekolk, J.E., Lankveld, W.G.J.M. van, Geenen, R. & Ende, C.H.M. van den (2011). Longitudinal association between coping and psychological distress in rheumatoid arthritis: a systematic review. Annals of the Rheumatic Diseases, 70, 1243-1250.
  31. Vriezekolk, J.E., Lankveld, W.G.J.M. van, Eijsbouts, A.M.M., Helmond, T. van, Geenen, R. & Ende, C.H.M. van den (2011). The coping flexibility questionnaire (COFLEX). Development and initial validation in patients with chronic rheumatic diseases. Rheumatology International.
  32. Wit, M.P. de , Berlo, S.E., Aanerud, G.J., Aletha, D., Bijlsma, J.W.J., Croucher, L., Da Silva, J.A., Glüsing, B., Gossec, L., Hewlett, S., Magnusson, D., Scholte-Voshaar, M., Richards, P., Ziegler, C. & Abma, T.A. (2011). European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Annals of the Rheumatic Diseases, 70(5), 722-726.

Professional publications 

  1. Goes, M.C. van der , Bossema, E.R. & Geenen, R. (2011). Wat weten we over cortisol bij patiënten met lupus erythematosus en de ziekte van Sjögren? Lupus Magazine, 74, 8-10. 
  2. Cost effectiveness of biologicals: High costs are the other face of success. Welsing, P.M., Bijl, M., Bodegraven A.A. van, Lems W.F., Prens E., Bijlsma J.W. (2011). Ned. Tijdschrift voor Geneeskunde, 155 (29) A3026.

Book (chapters) 

Geenen, R. & D' Agostino, R.B. (2011). Reumatische aandoeningen. In Psychologie en Geneeskunde. Houten: Bohn Stafleu Van Loghum.

Disclaimer© 2006-2012 UMC Utrecht, All rights reserved